Biomotion Sciences Valuation
| SLXN Stock | 2.89 0.49 20.42% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Biomotion Sciences shows a prevailing Real Value of USD5.14 per share. The current price of the firm is USD2.89. Our model approximates the value of Biomotion Sciences from analyzing the firm fundamentals such as Return On Equity of -1.17, current valuation of 1.91 M, and Shares Owned By Insiders of 4.60 % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Biomotion Sciences' valuation include:
Undervalued
Today
Please note that Biomotion Sciences' price fluctuation is risky at this time. Calculation of the real value of Biomotion Sciences is based on 3 months time horizon. Increasing Biomotion Sciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Biomotion Sciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Biomotion Stock. However, Biomotion Sciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.89 | Real 5.14 | Target 12.0 | Hype 2.28 |
The intrinsic value of Biomotion Sciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Biomotion Sciences' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Biomotion Sciences Ordinary helps investors to forecast how Biomotion stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Biomotion Sciences more accurately as focusing exclusively on Biomotion Sciences' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Biomotion Sciences' intrinsic value based on its ongoing forecasts of Biomotion Sciences' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Biomotion Sciences' closest peers.
Biomotion Sciences Cash |
|
Biomotion Sciences Total Value Analysis
Biomotion Sciences Ordinary is at this time anticipated to have valuation of 1.91 M with market capitalization of 9.04 M, debt of 4.49 M, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Biomotion Sciences fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.91 M | 9.04 M | 4.49 M |
Biomotion Sciences Asset Utilization
One of the ways to look at asset utilization of Biomotion is to check how much profit was generated for every dollar of assets it reports. Biomotion Sciences Ordinary shows a negative utilization of assets of -1.94 percent, losing USD0.0194 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Biomotion Sciences Ordinary shows how discouraging it operates for each dollar spent on its assets.Biomotion Sciences Ownership Allocation
Biomotion Sciences Ordinary shows 4.6 percent of its outstanding shares held by insiders and 8.48 percent owned by other corporate entities.Biomotion Sciences Profitability Analysis
Net Loss for the year was (16.52 M) with profit before overhead, payroll, taxes, and interest of 0.About Biomotion Sciences Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Biomotion Sciences Ordinary. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Biomotion Sciences based exclusively on its fundamental and basic technical indicators. By analyzing Biomotion Sciences's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Biomotion Sciences's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Biomotion Sciences. We calculate exposure to Biomotion Sciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Biomotion Sciences's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -22.5 K | -23.6 K |
Biomotion Sciences Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 6.2 M |
Biomotion Sciences Current Valuation Indicators
Biomotion Sciences' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Biomotion Sciences' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Biomotion Sciences, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Biomotion Sciences' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Biomotion Sciences' worth.When determining whether Biomotion Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biomotion Sciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biomotion Sciences Ordinary Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biomotion Sciences Ordinary Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Biomotion Sciences Ordinary. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in national income and product accounts. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomotion Sciences. If investors know Biomotion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomotion Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Biomotion Sciences is measured differently than its book value, which is the value of Biomotion that is recorded on the company's balance sheet. Investors also form their own opinion of Biomotion Sciences' value that differs from its market value or its book value, called intrinsic value, which is Biomotion Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomotion Sciences' market value can be influenced by many factors that don't directly affect Biomotion Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomotion Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomotion Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomotion Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.